Rare diseases
Investigational molecules
Locations
Back to Greece260 clinical trials in Patras, Greece across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on Long-Term Safety and Efficacy of BI 1291583 in Patients with Bronchiectasis
GreeceStudy Comparing Selinexor, Pomalidomide, and Dexamethasone with Elotuzumab, Pomalidomide, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma
GreeceStudy on Golexanolone for Patients with Primary Biliary Cholangitis Experiencing Fatigue and Cognitive Dysfunction
GreeceStudy on Emapalumab for Patients with Sepsis Linked to Interferon-Gamma
GreeceStudy on the Effects of Cenerimod for Adults with Moderate to Severe Systemic Lupus Erythematosus
GreeceStudy on the Effects of CDR132L in Patients with Reduced Heart Function After a Heart Attack
GreeceStudy on the Risk of Tumor Lysis Syndrome in Adults with Untreated Chronic Lymphocytic Leukemia Using Venetoclax, Obinutuzumab, or Acalabrutinib
GreeceStudy on Birtamimab and Bortezomib for Patients with Advanced Light Chain Amyloidosis
GreeceThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Sjögren's Syndrome and Systemic Sclerosis, evaluating novel therapeutic approaches with medications like sibeprenlimab and efgartigimod. These trials aim to improve treatment outcomes for patients with chronic autoimmune disorders.
Studies are exploring both long-term safety and immediate efficacy of new treatment options.
Comprehensive studies in Multiple Myeloma and advanced cancers, including trials of combination therapies and novel treatments. Research includes investigations into treatments for newly diagnosed and relapsed/refractory cases.
Focus on improving patient outcomes through targeted and combination therapies.
Groundbreaking research in Amyotrophic Lateral Sclerosis and Myasthenia Gravis, evaluating innovative treatments and therapeutic approaches for these challenging neurological conditions.
Studies are examining both disease progression and symptom management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
